We recently compiled a list of the 10 Best Performing Real Estate Stocks to Buy According to Analysts. In this article, we ...

The Central Bank of Libya (CBL) stated that it has no connection to the website “cbl.cards”, which falsely claims to provide ...

Caliway Biopharmaceuticals (TWSE: 6919) announced that clinical results from the CBL-0202 Phase 2 study of its novel localized fat reduction drug, CBL-514, have been accepted for publication in the ...

In a widely leaked official letter to the Governor of the Central Bank of Libya (CBL), Naji Issa, the Tripoli based Libyan Prime Minister, Abel Hamid Aldabaiba, called on the CBL to take urgent ...

The Special Representative of the Secretary-General and Head of the United Nations Support Mission in Libya (UNSMIL), Hanna ...

1 Day CBL -2.87% DJIA -1.06% S&P Mid Cap 400 -1.00% Real Estate/Construction -2.98% ...

Advancing Scientific Recognition in Non-Surgical Fat Reduction Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal ...

We are facing a challenging environment. Some REITs may not survive it. Find out two REITs that could be facing significant ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Caliway’s CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery. Clinical data (ITT ...